US Patent Issued to Alchemab Therapeutics on Sept. 15 for "Engineering of antigen-binding proteins" (British Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,738,343, issued on Sept. 15, was assigned to Alchemab Therapeutics Ltd (London).

"Engineering of antigen-binding proteins" was invented by Jinwoo Leem (London) and Jacob Galson (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of identifying an antigen-binding protein comprising a pair of chains are described. The methods comprise providing a query sequence comprising a first chain sequence, and identifying a corresponding chain sequence by providing the query sequence to a deep learning model configured to take as input a query first chain sequence and to produce as output at least one corresponding chain sequence, thereby identifying a c...